Red and near-infrared light therapy relies on specific wavelengths that interact with tissue in different ways. In equine photobiomodulation (PBM), wavelength selection matters because horses have dense tissue, large joints, and a wide range of application goals—from surface-level support to deeper soft-tissue and joint-adjacent areas.

Understanding how different wavelengths are commonly used helps set realistic expectations and supports appropriate application as part of a broader equine care program.

​

​

​

Why Wavelength Matters in Equine Photobiomodulation

Photobiomodulation research commonly identifies wavelength as one of the primary variables influencing how light interacts with tissue. Different wavelengths are associated with different depths of interaction and are selected based on the area being supported, tissue type, and intended application.

Wavelength alone does not determine outcomes. Dose, placement, duration, frequency, and individual response all play important roles. For this reason, multi-wavelength systems are often used in equine applications to support a broader range of tissue depths rather than relying on a single output.

660nm Red Light (Surface-Level Interaction)

Red light in the 660nm range is commonly associated with more superficial tissue interaction. In PBM literature, this wavelength is often discussed in relation to skin-level tissue, surface structures, and cellular signaling processes.

In equine use, 660nm is typically selected where surface or near-surface support is appropriate and is frequently combined with near-infrared wavelengths rather than used alone.

 

850nm Near-Infrared Light (Soft-Tissue Interaction)-infrared light around 850nm is widely used in photobiomodulation for deeper soft-tissue contexts. This wavelength is commonly associated with muscle tissue, tendons, ligaments, fascia, and joint-adjacent structures in both human and veterinary settings.

In horses, 850nm is frequently used to support larger muscle groups and deeper structures where visible red light may have limited interaction on its own.

​

940nm Near-Infrared Light (Deep & Dense Tissue Contexts)

940nm is another near-infrared wavelength used in deeper tissue contexts. It is often included in systems designed for large joints and dense tissue regions commonly found in equine anatomy.

Rather than replacing other wavelengths, 940nm is typically used to broaden depth coverage as part of a multi-wavelength approach. The inclusion of multiple near-infrared wavelengths reflects the reality that equine tissue depth, joint size, and circulation demands vary significantly, and no single wavelength is appropriate for all applications.

​

​

​

ReGen Equine’s Tri-Wave™ Wavelength Structure

ReGen Equine devices are built around a Tri-Wave™ wavelength structure, combining 660nm, 850nm, and 940nm within the same system.

Tri-Wave is not a separate therapy type. It is ReGen Equine’s application of wavelength science to equine anatomy, designed to support layered tissue interaction rather than isolating a single depth.

This approach aligns with how photobiomodulation is commonly discussed in research and applied in practice, where wavelength selection is matched to tissue depth and application rather than relying on one output to serve all purposes.

Practical Considerations & Expectations

Wavelength selection should always be considered alongside appropriate use, consistency, and realistic expectations. Red and near-infrared light therapy is intended as supportive care, not as a medical treatment or replacement for veterinary diagnosis.

Individual response varies, and light therapy is most effective when integrated thoughtfully into a comprehensive equine care plan.

For practical questions related to application, safety, and general use considerations, visit:

​